<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>ç§‘ç ”æ—¥æŠ¥ 2026-01-28 - ç”Ÿä¿¡æ™®æ‹‰æ–¯</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/dailyreports/2026-01-28/"><meta property="og:site_name" content="ç”Ÿä¿¡æ™®æ‹‰æ–¯"><meta property="og:title" content="ç§‘ç ”æ—¥æŠ¥ 2026-01-28"><meta property="og:description" content="ğŸ“… Daily Report - 2026-01-28 ä»Šæ—¥ç­›é€‰å‡º 77 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2026-01-28T00:00:00+00:00"><meta property="article:modified_time" content="2026-01-28T00:00:00+00:00"><meta property="article:tag" content="Research"><meta property="article:tag" content="Daily"><meta property="article:tag" content="Week052026"><meta itemprop=name content="ç§‘ç ”æ—¥æŠ¥ 2026-01-28"><meta itemprop=description content="ğŸ“… Daily Report - 2026-01-28 ä»Šæ—¥ç­›é€‰å‡º 77 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><meta itemprop=datePublished content="2026-01-28T00:00:00+00:00"><meta itemprop=dateModified content="2026-01-28T00:00:00+00:00"><meta itemprop=wordCount content="2384"><meta itemprop=keywords content="Research,Daily,Week052026"><meta name=twitter:card content="summary"><meta name=twitter:title content="ç§‘ç ”æ—¥æŠ¥ 2026-01-28"><meta name=twitter:description content="ğŸ“… Daily Report - 2026-01-28 ä»Šæ—¥ç­›é€‰å‡º 77 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=ç”Ÿä¿¡æ™®æ‹‰æ–¯ rel=home><div class="logo__item logo__text"><div class=logo__title>ç”Ÿä¿¡æ™®æ‹‰æ–¯</div><div class=logo__tagline>è¿‘åå¹´æœ€å€¼å¾—ä¸Šæ‰‹çš„ç”Ÿç‰©åŒ»å­¦ç”Ÿä¿¡ä»£ç </div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>æ–‡ç« </span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>æ ‡ç­¾</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>å…³äº</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>ç§‘ç ”æ—¥æŠ¥ 2026-01-28</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2026-01-28T00:00:00Z>2026-01-28</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/dailyreport/ rel=category>DailyReport</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</a><ul><li><a href=#-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</a></li><li><a href=#-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</a></li></ul></li><li><a href=#-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</a><ul><li></li></ul></li><li><a href=#-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</a></li><li><a href=#-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</a></li></ul></nav></div></div><div class="content post__content clearfix"><h1 id=-daily-report---2026-01-28>ğŸ“… Daily Report - 2026-01-28</h1><blockquote><p>ä»Šæ—¥ç­›é€‰å‡º <strong>77</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>2</strong> ä¸ªæ¥æº</p></blockquote><div class=powered-by-top>Powered by <a href=https://kyplus.de>ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href=https://claude.ai>Claude</a></div><hr><h2 id=-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2><h3 id=-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
é€šè¿‡ in vivo CRISPR æ¿€æ´»ç­›é€‰ï¼Œå®ç°äº†è‚¿ç˜¤å¾®ç¯å¢ƒå…ç–«åŸºå› ç–—æ³•ç»„åˆçš„ç†æ€§è®¾è®¡ï¼Œä¸ºè‚¿ç˜¤å…ç–«æ²»ç–—æä¾›äº†æ–°ç­–ç•¥ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li><strong>è‚¿ç˜¤å…ç–«ä¸åŸºå› ç–—æ³•</strong>ï¼šåˆ©ç”¨ CRISPR æ¿€æ´»ç­›é€‰ä¼˜åŒ–è‚¿ç˜¤å¾®ç¯å¢ƒå…ç–«åŸºå› ç–—æ³•ã€‚</li><li><strong>å¿ƒè‚Œä¿®å¤ä¸ä»£è°¢é‡ç¼–ç¨‹</strong>ï¼šé€šè¿‡é¶å‘ NPM1 è¡¨è§‚é—ä¼ è°ƒæ§ï¼Œä¿ƒè¿›å¿ƒè‚Œæ¢—æ­»åä¿®å¤ã€‚</li><li><strong>æŠ—è‚¿ç˜¤å…ç–«ä¸çº¿ç²’ä½“ä»£è°¢</strong>ï¼šè§£æçº¿ç²’ä½“ä»£è°¢å¯¹æ ‘çªçŠ¶ç»†èƒæŠ—è‚¿ç˜¤åŠŸèƒ½çš„å½±å“ã€‚</li><li><strong>åŒ–ç–—è€è¯æœºåˆ¶</strong>ï¼šç ”ç©¶è‚¾è„å‘è‚²ç»†èƒçŠ¶æ€ä¸ Wilms ç˜¤åŒ–ç–—è€è¯çš„å…³ç³»ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li><strong>CRISPR æ¿€æ´»ç­›é€‰</strong>ï¼šåœ¨ä½“å†…è¿›è¡Œé«˜é€šé‡ç­›é€‰ï¼Œç”¨äºå…ç–«åŸºå› ç–—æ³•çš„ç»„åˆè®¾è®¡ã€‚</li><li><strong>ç©ºé—´è½¬å½•ç»„å­¦</strong>ï¼šåº”ç”¨äºè‚ºç™Œæ—©æœŸè¯Šæ–­ï¼Œæ£€æµ‹è¡€ç®¡ä¾µè¢­ç›¸å…³åŸºå› è¡¨è¾¾ã€‚</li></ul><h3 id=-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
æ­ç¤ºç™Œç—‡è¿›åŒ–æ–°è§„åˆ™ï¼Œå‘ç°é©±åŠ¨è‚¿ç˜¤ç”Ÿé•¿ä¸”å¯ç”¨äºæ¶²ä½“æ´»æ£€çš„éç¼–ç RNAï¼ˆoncRNAï¼‰ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>ç™Œç—‡è¿›åŒ–æœºåˆ¶ï¼šæ­ç¤ºç™Œç—‡ç»†èƒè·å¾—æˆ–ä¸¢å¤±æ•´æ¡æŸ“è‰²ä½“çš„éšè—è§„åˆ™ã€‚</li><li>ç™Œç—‡æ—©æœŸè¯Šæ–­ä¸ç›‘æµ‹ï¼šåˆ©ç”¨oncRNAä½œä¸ºåˆ†å­æ¡å½¢ç ï¼Œå®ç°åŸºäºè¡€æ¶²çš„ç™Œç—‡è´Ÿæ‹…å’Œé¢„åç›‘æµ‹ã€‚</li><li>é£Ÿå“æ·»åŠ å‰‚ä¸ç™Œç—‡å…³è”ï¼šå‘ç°å¸¸è§é£Ÿå“æ·»åŠ å‰‚ä¸ç™Œç—‡é£é™©çš„æ½œåœ¨è”ç³»ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>æ–°å‹åŒä¸Šä¸‹æ–‡æ„ŸçŸ¥ç¢±åŸºè¯†åˆ«å™¨ï¼ˆCoralï¼‰ï¼šæ˜¾è‘—æå‡çº³ç±³å­”ç›´æ¥RNAæµ‹åºçš„å‡†ç¡®æ€§ï¼Œä¼˜åŒ–è½¬å½•æœ¬å¼‚æ„ä½“æ£€æµ‹å’Œå•å€å‹åˆ†å‹ã€‚</li><li>ç™Œç—‡è¿›åŒ–è§„åˆ™æ¨æ–­æ–¹æ³•ï¼šä¸€ç§å¼ºå¤§çš„æ–°æ–¹æ³•ï¼Œç”¨äºè§£æç™Œç—‡ç»†èƒåŸºå› ç»„å¤§è§„æ¨¡å˜åŒ–çš„å†…åœ¨è§„å¾‹ã€‚</li></ul><hr><h2 id=-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</h2><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§¬ æ•°æ®å‰æ²¿ (73æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>GSE255516 é€šè¿‡ä½“å†… CRISPR æ¿€æ´»ç­›é€‰è‚¿ç˜¤å¾®ç¯å¢ƒè°ƒèŠ‚å‰‚ï¼Œåˆç†è®¾è®¡å…ç–«åŸºå› æ²»ç–—ç»„åˆ [scRNA-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immuneã€tumor microenvironmentã€scRNA</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Feifei Zhang ; Ryan D Chow ; Chuanpeng Dong ; Emily He ; Lvyun Zhu ; Shan Xin ; Daniyal Mirza ; Yanzhi Feng ; Xinyu Ling ; Qin Han ; Sidi Chen ; Guangchuan WangSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThe hostile tumor microenvironment (TME) is major challenge for cancer immunotherapies. Here, we design and perform TME-targeted in vivo CRISPR activation (CRISPRa) screens to uncover factors that promote anti-tumor immunity, culminating in rationally designed immune gene therapy combinations. Through adeno-associated virus (AAV) delivery, we find that multiplexed activation of pooled immunoregulatory genes encoding antigen presentation, cytokine, and co-stimulation molecules (APCM) leads to enhanced anti-tumor immunity. A CRISPRa screen targeting APCM genes in metastatic tumors identifies CD80, TNFSF14, CXCL10, TNFSF18, TNFSF9, and IFNG as the top immunostimulatory candidates. Further optimization pinpoints 4-1BBL(TNFSF9) + IFNG + IL12B (4II) as a potent streamlined therapeutic combination. AAV delivered 4II has potent in vivo anti-tumor efficacy in multiple tumor models, by enhancing tumor antigen presentation while simultaneously promoting the infiltration, activation, and expansion of anti-tumor T cells. We further demonstrate that APCM therapy synergizes with CAR-T therapy against human solid tumors in vivo. CRISPRa screens and gene activation systems targeting APCM factors thus represent a powerful approach for rapid development of off-the-shelf immune gene therapies against solid tumors.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255516">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>GSE255514 é€šè¿‡ä½“å†… CRISPR æ¿€æ´»ç­›é€‰è‚¿ç˜¤å¾®ç¯å¢ƒè°ƒèŠ‚å‰‚ï¼Œåˆç†è®¾è®¡å…ç–«åŸºå› æ²»ç–—ç»„åˆ [æ‰¹é‡ RNA æµ‹åº]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immuneã€tumor microenvironmentã€RNA-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Feifei Zhang ; Ryan D Chow ; Chuanpeng Dong ; Emily He ; Lvyun Zhu ; Shan Xin ; Daniyal Mirza ; Yanzhi Feng ; Xinyu Ling ; Qin Han ; Sidi Chen ; Guangchuan WangSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThe hostile tumor microenvironment (TME) is major challenge for cancer immunotherapies. Here, we design and perform TME-targeted in vivo CRISPR activation (CRISPRa) screens to uncover factors that promote anti-tumor immunity, culminating in rationally designed immune gene therapy combinations. Through adeno-associated virus (AAV) delivery, we find that multiplexed activation of pooled immunoregulatory genes encoding antigen presentation, cytokine, and co-stimulation molecules (APCM) leads to enhanced anti-tumor immunity. A CRISPRa screen targeting APCM genes in metastatic tumors identifies CD80, TNFSF14, CXCL10, TNFSF18, TNFSF9, and IFNG as the top immunostimulatory candidates. Further optimization pinpoints 4-1BBL(TNFSF9) + IFNG + IL12B (4II) as a potent streamlined therapeutic combination. AAV delivered 4II has potent in vivo anti-tumor efficacy in multiple tumor models, by enhancing tumor antigen presentation while simultaneously promoting the infiltration, activation, and expansion of anti-tumor T cells. We further demonstrate that APCM therapy synergizes with CAR-T therapy against human solid tumors in vivo. CRISPRa screens and gene activation systems targeting APCM factors thus represent a powerful approach for rapid development of off-the-shelf immune gene therapies against solid tumors.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255514">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>GSE230944 é€šè¿‡è¡¨è§‚é—ä¼ å­¦é¶å‘ NPM1 ä¿ƒè¿›å¿ƒè‚Œæ¢—æ­»åä¿®å¤ï¼Œé‡ç¼–ç¨‹ä¿®å¤æ€§å·¨å™¬ç»†èƒä»£è°¢ [RNA-Seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šmacrophageã€metabolismã€cardiacã€RNA-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Zhenzhen Zhan ; Sheng ZhangSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusBackground: Post-infarction heart failure is attributed to ischemia-induced myocardial inflammation and unfavorable remodeling, with reparative macrophages playing a crucial role in limiting excessive fibrosis and promoting cardiac repair via cytokine secretion and cross-cell interactions. Hence, a timely and adequate transition of macrophage phenotypes is essential for proper wound healing post-MI, but the precise mechanisms underlying this process remain incompletely elucidated. Methods: To elucidate the function of NPM1 in post-infarct cardiac repair, we generated macrophage-specific NPM1 knockout mouse models. Additionally, Cut&amp;Tag assays were conducted on cardiac macrophages for the first time to explore the epigenetic mechanisms underlying NPM1-mediated regulation of macrophage metabolic reprogramming. Results: Macrophage-specific deletion of NPM1 in MI mouse models resulted in reduced tissue fibrosis and enhanced cardiac repair by promoting the phenotypic transition of macrophages towards a reparative state. NPM1 deletion also led to a shift in macrophage metabolism from glycolysis to mitochondrial OXPHOS via inactivation of the mTOR cascades. Mechanistically, we demonstrated that IL-4 induced NPM1 oligomerization, which recruited histone demethylase KDM5b to the promoter region of Tsc1, ultimately leading to macrophage metabolic rewiring. Antisense oligonucleotides and inhibitory compounds targeting NPM1 exhibited notable protective effects on cardiac repair post-MI. Conclusions: Our study demonstrates that NPM1 may serve as a promising prognostic biomarker and a valuable therapeutic target for ischemia-induced heart failure, shedding new light on the understanding of post-infarct cardiac repair and may pave the way for the development of innovative therapeutic strategies.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE230944">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> â­ <strong>GSE304687 çº¿ç²’ä½“ä»£è°¢å’Œä¿¡å·ä¼ å¯¼ç›´æ¥è°ƒæ§æ ‘çªçŠ¶ç»†èƒåœ¨æŠ—è‚¿ç˜¤å…ç–«ä¸­çš„åŠŸèƒ½ [ATAC-seq2]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmunityã€dendritic cellã€metabolism</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Hao Shi ; Zhiyuan You ; Hongbo ChiSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusATAC-seq profiling of intratumoral cDC1s</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304687">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> â­ <strong>GSE304510 çº¿ç²’ä½“ä»£è°¢å’Œä¿¡å·ä¼ å¯¼ç›´æ¥è°ƒæ§æ ‘çªçŠ¶ç»†èƒåœ¨æŠ—è‚¿ç˜¤å…ç–«ä¸­çš„åŠŸèƒ½ [microarray3]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmunityã€dendritic cellã€metabolism</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Hao Shi ; Zhiyuan You ; Hongbo ChiSeries Type : Expression profiling by arrayOrganism : Mus musculusTranscriptional dissection of intratumoral cDC1s</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304510">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> â­ <strong>GSE298478 è¯±å¯¼è‚¾è„å‘è‚²ç»†èƒçŠ¶æ€ä¸é¢„åè‰¯å¥½å‹ Wilms è‚¿ç˜¤çš„åŒ–ç–—è€è¯æ€§ç›¸å…³ [RNA-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€resistanceã€RNA-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Andrew J Murphy ; Hongjian JinSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensChildren with favorable histology Wilms tumor (FHWT) who experience disease relapse or whose tumors exhibit blastemal predominance after chemotherapy often have poor outcomes. We established a FHWT patient-derived xenograft model, KT-47, that exhibited blastemal predominance after chemotherapy treatment with vincristine, actinomycin, and doxorubicin (VAD) and ultimately developed complete resistance to VAD after serial exposures to this combination. Histologic analyses and comprehensive multi-omics approaches were used to evaluate changes associated with resistance. CUT&amp;TAG identified increased transcriptionally active H3K4me3 at stem cell and nephrogenesis gene promoters among the most different regions in KT-47 resistant compared to the KT-47 pretreatment model including the HOXB cluster, HOXC cluster, MYCN, SIX2, IGF2, CITED1, and OSR1. In contrast, decreased H3K27me3 was identified at HOX gene cluster and nephrogenesis gene promoter regions. The most significantly upregulated transcript and protein that associated with resistance in KT-47 was the let7 microRNA processor LIN28B. LIN28B upregulation was associated with copy number gain at MYCN and plasticity of cancer cells marked by open chromatin at the LIN28B locus rather than expansion of a minor subclone expressing LIN28B present in the original primary tumor material. The stem cell-associated multidrug resistance protein ABCB1 was upregulated in epithelial cells in association with an inter-chromosomal interaction between chromosomes 1 and 7. The impact of these findings at MYCN, LIN28B, and ABCB1 were validated in additional WT models and samples. Overall, these results support de-differentiation of FHWT cancer cells to a stem-like state which is associated with chemotherapy resistance. Targeting epigenetic modifiers that modulate differentiation of cancer cells with a stem-like phenotype could be a future treatment strategy in chemotherapy resistant FHWT.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298478">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> â­ <strong>GSE298463 è¯±å¯¼è‚¾è„å‘è‚²ç»†èƒçŠ¶æ€ä¸é¢„åè‰¯å¥½å‹ Wilms è‚¿ç˜¤çš„åŒ–ç–—è€è¯æ€§ç›¸å…³ [ç”²åŸºåŒ–]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€resistanceã€methylation</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Andrew J Murphy ; Hongjian JinSeries Type : Methylation profiling by genome tiling arrayOrganism : Homo sapiensChildren with favorable histology Wilms tumor (FHWT) who experience disease relapse or whose tumors exhibit blastemal predominance after chemotherapy often have poor outcomes. We established a FHWT patient-derived xenograft model, KT-47, that exhibited blastemal predominance after chemotherapy treatment with vincristine, actinomycin, and doxorubicin (VAD) and ultimately developed complete resistance to VAD after serial exposures to this combination. Histologic analyses and comprehensive multi-omics approaches were used to evaluate changes associated with resistance. CUT&amp;TAG identified increased transcriptionally active H3K4me3 at stem cell and nephrogenesis gene promoters among the most different regions in KT-47 resistant compared to the KT-47 pretreatment model including the HOXB cluster, HOXC cluster, MYCN, SIX2, IGF2, CITED1, and OSR1. In contrast, decreased H3K27me3 was identified at HOX gene cluster and nephrogenesis gene promoter regions. The most significantly upregulated transcript and protein that associated with resistance in KT-47 was the let7 microRNA processor LIN28B. LIN28B upregulation was associated with copy number gain at MYCN and plasticity of cancer cells marked by open chromatin at the LIN28B locus rather than expansion of a minor subclone expressing LIN28B present in the original primary tumor material. The stem cell-associated multidrug resistance protein ABCB1 was upregulated in epithelial cells in association with an inter-chromosomal interaction between chromosomes 1 and 7. The impact of these findings at MYCN, LIN28B, and ABCB1 were validated in additional WT models and samples. Overall, these results support de-differentiation of FHWT cancer cells to a stem-like state which is associated with chemotherapy resistance. Targeting epigenetic modifiers that modulate differentiation of cancer cells with a stem-like phenotype could be a future treatment strategy in chemotherapy resistant FHWT.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298463">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> â­ <strong>GSE285156 çº¿ç²’ä½“ä»£è°¢å’Œä¿¡å·ä¼ å¯¼ç›´æ¥å½±å“æ ‘çªçŠ¶ç»†èƒåœ¨æŠ—è‚¿ç˜¤å…ç–«ä¸­çš„åŠŸèƒ½ [microarray1]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmunityã€dendritic cellã€metabolism</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Hao Shi ; Zhiyuan You ; Hongbo ChiSeries Type : Expression profiling by arrayOrganism : Mus musculusTranscriptional dissection of cDC1s with polarized mitochondria or cDC1s with depolarized mitochondria</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285156">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> â­ <strong>GSE285155 çº¿ç²’ä½“ä»£è°¢å’Œä¿¡å·ä¼ å¯¼ç›´æ¥å½±å“æ ‘çªçŠ¶ç»†èƒåœ¨æŠ—è‚¿ç˜¤å…ç–«ä¸­çš„åŠŸèƒ½ [microarray2]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmunityã€dendritic cellã€metabolism</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Hao Shi ; Zhiyuan You ; Hongbo ChiSeries Type : Expression profiling by arrayOrganism : Mus musculusTranscriptional dissection of splenic WT and OPA1-deficient cDC1s</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285155">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> â­ <strong>GSE255515 é€šè¿‡ä½“å†… CRISPR æ¿€æ´»ç­›é€‰è‚¿ç˜¤å¾®ç¯å¢ƒè°ƒèŠ‚å‰‚ï¼Œåˆç†è®¾è®¡å…ç–«åŸºå› æ²»ç–—ç»„åˆ [CRISPR]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immuneã€tumor microenvironment</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Feifei Zhang ; Ryan D Chow ; Chuanpeng Dong ; Emily He ; Lvyun Zhu ; Shan Xin ; Daniyal Mirza ; Yanzhi Feng ; Xinyu Ling ; Qin Han ; Sidi Chen ; Guangchuan WangSeries Type : OtherOrganism : Mus musculusThe hostile tumor microenvironment (TME) is major challenge for cancer immunotherapies. Here, we design and perform TME-targeted in vivo CRISPR activation (CRISPRa) screens to uncover factors that promote anti-tumor immunity, culminating in rationally designed immune gene therapy combinations. Through adeno-associated virus (AAV) delivery, we find that multiplexed activation of pooled immunoregulatory genes encoding antigen presentation, cytokine, and co-stimulation molecules (APCM) leads to enhanced anti-tumor immunity. A CRISPRa screen targeting APCM genes in metastatic tumors identifies CD80, TNFSF14, CXCL10, TNFSF18, TNFSF9, and IFNG as the top immunostimulatory candidates. Further optimization pinpoints 4-1BBL(TNFSF9) + IFNG + IL12B (4II) as a potent streamlined therapeutic combination. AAV delivered 4II has potent in vivo anti-tumor efficacy in multiple tumor models, by enhancing tumor antigen presentation while simultaneously promoting the infiltration, activation, and expansion of anti-tumor T cells. We further demonstrate that APCM therapy synergizes with CAR-T therapy against human solid tumors in vivo. CRISPRa screens and gene activation systems targeting APCM factors thus represent a powerful approach for rapid development of off-the-shelf immune gene therapies against solid tumors.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255515">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 63 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E6%95%B0%E6%8D%AE%E5%89%8D%E6%B2%BF>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§ª åšå®¢æ›´æ–° (4æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨4æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨4æ¡ï¼‰</h4><p><strong>1.</strong> <strong>æ­ç¤ºç™Œç—‡ä¸­éšè—çš„ oncRNA ç‰¹å¾â€”â€”ä»å‘ç°åˆ°æ¶²ä½“æ´»æ£€</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šLarge-scale RNA sequencing reveals cancer-specific orphan RNAs that act as molecular barcodes, drive tumor growth, and enable blood-based monitoring of cancer burden and patient outcomes&mldr;</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/uncovering-cancers-hidden-oncrna-signatures-from-discovery-to-liquid-biopsy/>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> <strong>ä¸€ç§ç”¨äºçº³ç±³å­”ç›´æ¥RNAæµ‹åºçš„åŒé‡ä¸Šä¸‹æ–‡æ„ŸçŸ¥ç¢±åŸºè¯†åˆ«å™¨</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencing</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šA new dual context-aware basecaller, Coral, markedly improves nanopore direct RNA sequencing accuracy, enabling better detection of transcript isoforms and more reliable haplotype phasing&mldr;</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/a-dual-context-aware-basecaller-for-nanopore-direct-rna-sequencing/>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> <strong>ç§‘å­¦å®¶ä»¬åˆšåˆšç ´è§£äº†ç™Œç—‡è¿›åŒ–çš„éšè—è§„å¾‹ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šCancer doesnâ€™t evolve by pure chaos. Scientists have developed a powerful new method that reveals the hidden rules guiding how cancer cells gain and lose whole chromosomesâ€”massive genetic shifts that help tumors grow, adapt, and survive treatment. By tracking thousands of individual cells over time, the approach shows which chromosome combinations give cancer an edge and why some tumors become especially resilient.</li><li>ğŸ”— <a href=https://www.sciencedaily.com/releases/2026/01/260125083344.htm>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> <strong>è¿™äº›å¸¸è§çš„é£Ÿå“é˜²è…å‰‚å¯èƒ½ä¸ç™Œç—‡æœ‰å…³ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šA large French study tracking more than 100,000 people over a decade has found that higher consumption of certain food preservativesâ€”commonly found in processed foods and drinksâ€”is linked to a modestly higher cancer risk. While many preservatives showed no association, several widely used ones, including potassium sorbate, sulfites, sodium nitrite, and potassium nitrate, were tied to increased risks of overall cancer and specific types such as breast and prostate cancer.</li><li>ğŸ”— <a href=https://www.sciencedaily.com/releases/2026/01/260127010154.htm>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><h2 id=-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2><table><thead><tr><th>å…³é”®è¯</th><th>å‡ºç°æ¬¡æ•°</th></tr></thead><tbody><tr><td>RNA-seq</td><td>16</td></tr><tr><td>ChIP-seq</td><td>11</td></tr><tr><td>histone</td><td>10</td></tr><tr><td>sequencing</td><td>7</td></tr><tr><td>metabolism</td><td>7</td></tr><tr><td>tumor</td><td>7</td></tr><tr><td>transcriptome</td><td>6</td></tr><tr><td>regex:onco(logy</td><td>logist</td></tr><tr><td>single-cell</td><td>6</td></tr><tr><td>cancer</td><td>5</td></tr><tr><td>immunity</td><td>5</td></tr><tr><td>macrophage</td><td>5</td></tr><tr><td>dendritic cell</td><td>4</td></tr><tr><td>resistance</td><td>4</td></tr><tr><td>methylation</td><td>3</td></tr><tr><td>immune</td><td>3</td></tr><tr><td>tumor microenvironment</td><td>3</td></tr><tr><td>cardiac</td><td>3</td></tr><tr><td>transcriptomics</td><td>3</td></tr><tr><td>scRNA</td><td>2</td></tr></tbody></table><hr><h2 id=-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</h2><details><summary><a name=æ›´å¤š-æ•°æ®å‰æ²¿></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (63æ¡)</summary><div class=details-content markdown=1><ul><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE230949">GSE230949 é€šè¿‡è¡¨è§‚é—ä¼ å­¦é¶å‘ NPM1 é‡ç¼–ç¨‹ä¿®å¤æ€§å·¨å™¬ç»†èƒä»£è°¢ä¿ƒè¿›æ¢—æ­»åå¿ƒè„ä¿®å¤</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE230938">GSE230938 é€šè¿‡è¡¨è§‚é—ä¼ å­¦é¶å‘ NPM1 ä¿ƒè¿›å¿ƒè‚Œæ¢—æ­»åä¿®å¤ï¼Œé‡ç¼–ç¨‹ä¿®å¤æ€§å·¨å™¬ç»†èƒä»£è°¢ [CUT&amp;Tag]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE273378">GSE273378 è¡€ç®¡ä¾µè¢­ç›¸å…³åŸºå› è¡¨è¾¾å¯åœ¨ I æœŸè‚ºè…ºç™Œæœ¯å‰æ´»æ£€ä¸­æ£€æµ‹åˆ° [ç©ºé—´è½¬å½•ç»„å­¦]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317327">GSE317327 é€šè¿‡ç©ºé—´å’Œå•ç»†èƒè½¬å½•ç»„å­¦æ­ç¤ºäººç±»è‚Œè…±åœ¨æ•´ä¸ªç”Ÿå‘½å‘¨æœŸä¸­çš„ç»†èƒå’Œåˆ†å­å›¾è°±</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312719">GSE312719 å¯¹ HUVEC å•å±‚ç»†èƒå•ç‹¬åŸ¹å…»æˆ–æš´éœ²äºï¼ˆç»†èŒæ„ŸæŸ“çš„ï¼‰å·¨å™¬ç»†èƒæ · U937 ç»†èƒ 8 å°æ—¶åçš„å•ç»†èƒ RNA æµ‹åºåˆ†æã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311583">GSE311583 é€šè¿‡æŠ‘åˆ¶ cGAS-STING é€šè·¯å‡å¼± AAV è§¦å‘çš„æˆå¹´å°é¼ ç¥ç»ç³»ç»Ÿä¸­çš„å…ˆå¤©å…ç–«</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298482">GSE298482 è¯±å¯¼è‚¾è„å‘è‚²ç»†èƒçŠ¶æ€ä¸é¢„åè‰¯å¥½å‹ Wilms è‚¿ç˜¤çš„åŒ–ç–—è€è¯æ€§ç›¸å…³ [HiC]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298479">GSE298479 è¯±å¯¼è‚¾è„å‘è‚²ç»†èƒçŠ¶æ€ä¸é¢„åè‰¯å¥½çš„ Wilms è‚¿ç˜¤çš„åŒ–ç–—è€è¯æ€§ç›¸å…³ [CUT&amp;Tag]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE270217">GSE270217 åå¼ä½œç”¨é•¿é“¾éç¼–ç RNAè°ƒèŠ‚ä¸è‡´ç™ŒMYCä¿¡å·ç›¸å…³çš„é•¿ç¨‹æŸ“è‰²è´¨ç›¸äº’ä½œç”¨[RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE270212">GSE270212 åå¼ä½œç”¨é•¿é“¾éç¼–ç  RNA è°ƒèŠ‚ä¸è‡´ç™Œ MYC ä¿¡å·ç›¸å…³çš„é•¿ç¨‹æŸ“è‰²è´¨ç›¸äº’ä½œç”¨ [ATAC-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE208740">GSE208740 åå¼ä½œç”¨é•¿é“¾éç¼–ç RNAè°ƒèŠ‚ä¸è‡´ç™ŒMYCä¿¡å·ç›¸å…³çš„é•¿ç¨‹æŸ“è‰²è´¨ç›¸äº’ä½œç”¨[RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316386">GSE316386 Rpd3 ç»„è›‹ç™½å»ä¹™é…°åŒ–é…¶å¯¹äººç±»çœŸèŒç—…åŸä½“ç»„ç»‡èƒæµ†èŒçš„æ¸©åº¦ä»‹å¯¼çš„å½¢æ€å‘ç”Ÿå’Œæ¯’åŠ›è‡³å…³é‡è¦ â€“ HDACi ç»„è›‹ç™½ä¹™é…°åŒ– ChIP-seq (PE)</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316355">GSE316355 Rpd3 ç»„è›‹ç™½å»ä¹™é…°åŒ–é…¶å¯¹äººç±»çœŸèŒç—…åŸä½“ç»„ç»‡èƒæµ†èŒçš„æ¸©åº¦ä»‹å¯¼çš„å½¢æ€å‘ç”Ÿå’Œæ¯’åŠ›è‡³å…³é‡è¦â€”â€”HDAC çªå˜ä½“ç»„è›‹ç™½ä¹™é…°åŒ– ChIP-seq</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316185">GSE316185 Rpd3 ç»„è›‹ç™½å»ä¹™é…°åŒ–é…¶å¯¹äººç±»çœŸèŒç—…åŸä½“ç»„ç»‡èƒæµ†èŒçš„æ¸©åº¦ä»‹å¯¼çš„å½¢æ€å‘ç”Ÿå’Œæ¯’åŠ›è‡³å…³é‡è¦ â€“ HDACi ç»„è›‹ç™½ä¹™é…°åŒ– ChIP-seq (SE)</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316184">GSE316184 Rpd3ç»„è›‹ç™½å»ä¹™é…°åŒ–é…¶å¯¹äººç±»çœŸèŒç—…åŸä½“ç»„ç»‡èƒæµ†èŒçš„æ¸©åº¦ä»‹å¯¼çš„å½¢æ€å‘ç”Ÿå’Œæ¯’åŠ›è‡³å…³é‡è¦â€”â€”HDACçªå˜ä½“TF ChIP-seq</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316014">GSE316014 Rpd3ç»„è›‹ç™½å»ä¹™é…°åŒ–é…¶å¯¹äººç±»çœŸèŒç—…åŸä½“ç»„ç»‡èƒæµ†èŒçš„æ¸©åº¦ä»‹å¯¼çš„å½¢æ€å‘ç”Ÿå’Œæ¯’åŠ›è‡³å…³é‡è¦ â€“ HDACi TF ChIP-seq</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315932">GSE315932 Rpd3ç»„è›‹ç™½å»ä¹™é…°åŒ–é…¶å¯¹äººç±»çœŸèŒç—…åŸä½“ç»„ç»‡èƒæµ†èŒçš„æ¸©åº¦ä»‹å¯¼çš„å½¢æ€å‘ç”Ÿå’Œæ¯’åŠ›è‡³å…³é‡è¦â€”â€”HDACçªå˜ä½“RNAæµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315800">GSE315800 Rpd3 ç»„è›‹ç™½å»ä¹™é…°åŒ–é…¶å¯¹äººç±»çœŸèŒç—…åŸä½“ç»„ç»‡èƒæµ†èŒçš„æ¸©åº¦ä»‹å¯¼çš„å½¢æ€å‘ç”Ÿå’Œæ¯’åŠ›è‡³å…³é‡è¦â€”â€”HDACi RNA-seq</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295353">GSE295353 ä¼˜åŒ–å•ç»†èƒé•¿è¯»é•¿æµ‹åºä»¥å¢å¼ºèƒ°å²›åŒå·¥å‹æ£€æµ‹ [sc_islet]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295352">GSE295352 ä¼˜åŒ–å•ç»†èƒé•¿è¯»é•¿æµ‹åºä»¥å¢å¼ºèƒ°å²›ä¸­åŒå·¥å‹çš„æ£€æµ‹ [sc_spleen]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295351">GSE295351 ä¼˜åŒ–å•ç»†èƒé•¿è¯»é•¿æµ‹åºä»¥å¢å¼ºèƒ°å²›ä¸­å¼‚æ„ä½“æ£€æµ‹ [bulk_islet]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292142">GSE292142 è¶…è¶Š BRCA ç¼ºé™·ï¼šBRCA ç¼ºé™·å‹è¾“åµç®¡åµå·¢é«˜çº§åˆ«æµ†æ¶²æ€§ç™Œæ‚£è€…ç”Ÿå­˜çš„ä¸´åºŠå’Œåˆ†å­é¢„æµ‹å› å­ [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292140">GSE292140 è¶…è¶Š BRCA ç¼ºé™·ï¼šBRCA ç¼ºé™·å‹è¾“åµç®¡åµå·¢é«˜çº§åˆ«æµ†æ¶²æ€§ç™Œæ‚£è€…ç”Ÿå­˜çš„ä¸´åºŠå’Œåˆ†å­é¢„æµ‹å› å­ [ç”²åŸºåŒ–]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317702">GSE317702 TCRäº²å’ŒåŠ›ä»¥æŠ—åŸå‰‚é‡ä¾èµ–çš„æ–¹å¼æ§åˆ¶CD8 Tç»†èƒçš„ç«äº‰é€‚åº”æ€§ï¼Œä½†ä¸èƒ½å¯é åœ°é¢„æµ‹å…¶å‘½è¿ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314315">GSE314315 Xå°„çº¿æ´»åŒ–é“‚å¤åˆç‰©é€šè¿‡è¿œéš”æ•ˆåº”è¯±å¯¼DNAæŸä¼¤å¹¶å¢å¼ºç™Œç—‡å…ç–«ç–—æ³•</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289852">åˆ©ç”¨ H3ã€H3K4me1ã€H3K4me2 å’Œ H3K4me3 æŠ—ä½“å¯¹æ°´ç¨» NiP å’Œ osldl3 ä¸­çš„ç»„è›‹ç™½ä¿®é¥°è¿›è¡Œ ChIP-seq åˆ†æï¼ˆGSE289852ï¼‰</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266898">åˆ©ç”¨ H3ã€H3K4me1ã€H3K4me2ã€H3K4me3ã€H3K36me1ã€H3K36me2 å’Œ H3K36me3 æŠ—ä½“å¯¹æ°´ç¨» NiPã€ehd3-1ã€sdg724-1 å’Œ ehd3sdg724 ä¸­çš„ç»„è›‹ç™½ä¿®é¥°è¿›è¡Œ ChIP-seq åˆ†æï¼ˆGSE266898ï¼‰ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316932">GSE316932 AMPK çªå˜ä½“ dauer è½¬å½•ç»„ [RNA-seq daf2_aak_alg34]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316835">GSE316835 3â€™tRNAAsp(GTC)è¡ç”Ÿç‰‡æ®µå°†ç‚ç—‡ä¸éª¨å…³èŠ‚ç‚æœŸé—´è½¯éª¨ç»†èƒçš„è½¬å½•åé‡ç¼–ç¨‹è”ç³»èµ·æ¥ã€‚[è½¯éª¨å°RNAæµ‹åº]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316834">GSE316834 3â€™tRNAAsp(GTC)è¡ç”Ÿç‰‡æ®µå°†ç‚ç—‡ä¸éª¨å…³èŠ‚ç‚æœŸé—´è½¯éª¨ç»†èƒçš„è½¬å½•åé‡ç¼–ç¨‹è”ç³»èµ·æ¥ã€‚[åŸä»£è½¯éª¨ç»†èƒå°RNAæµ‹åº]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296345">GSE296345 å¯¹æš´éœ²äºæœªæ„ŸæŸ“æˆ–ç»†èŒæ„ŸæŸ“çš„ PMA åˆ†åŒ–å·¨å™¬ç»†èƒæ · U937 8 æˆ– 24 å°æ—¶çš„åŸä»£äººè„é™è„‰å†…çš®ç»†èƒ (HUVEC) è¿›è¡ŒåŒç«¯ RNA æµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288127">GSE288127 H3K27me3 è¡¨è§‚é—ä¼ æ ‡è®°å¯¹æ„ˆä¼¤ç»„ç»‡ç»†èƒç‰¹æ€§å’Œå†ç”Ÿèƒ½åŠ›è‡³å…³é‡è¦ [ChIP-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316913">GSE316913 ç¼¬æ°¨éœ‰ç´ å¤„ç†çš„æ‹Ÿå—èŠ¥è½¬å½•ç»„åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311009">GSE311009 äººç±»iPSCæ„å»ºçš„Tauè›‹ç™½ç—…æ¨¡å‹ï¼Œç»åŸºå› å·¥ç¨‹æ”¹é€ åå¯å†…æºæ€§è¡¨è¾¾4R Tauäºšå‹ï¼Œå¹¶å‘å±•ä¸ºæ™šæœŸç¥ç»å…ƒTauè›‹ç™½ç—…ç†ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310475">GSE310475 é¶å‘è‚‰ç˜¤èåˆåŸºå›  (FUS)ï¼šæ²»ç–—ç‰¹å‘æ€§è‚ºçº¤ç»´åŒ–çš„æ–°å‹åä¹‰ç­–ç•¥ [RNA-Seq PCLS]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310473">GSE310473 é¶å‘è‚‰ç˜¤èåˆåŸºå›  (FUS)ï¼šæ²»ç–—ç‰¹å‘æ€§è‚ºçº¤ç»´åŒ–çš„æ–°å‹åä¹‰ç­–ç•¥ [RNA-Seq IPF]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310070">GSE310070 å®«é¢ˆç™Œæ‚£è€…å’Œå¥åº·å¯¹ç…§ç»„è¡€æµ†ç»†èƒå¤–å›Šæ³¡ miRNA è°±åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309995">GSE309995 åå¼ä½œç”¨é•¿é“¾éç¼–ç RNAè°ƒèŠ‚ä¸è‡´ç™ŒMYCä¿¡å·ç›¸å…³çš„é•¿ç¨‹æŸ“è‰²è´¨ç›¸äº’ä½œç”¨[VCaP_HiChIP]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309994">GSE309994 åå¼ä½œç”¨é•¿é“¾éç¼–ç  RNA è°ƒèŠ‚ä¸è‡´ç™Œ MYC ä¿¡å·ç›¸å…³çš„é•¿ç¨‹æŸ“è‰²è´¨ç›¸äº’ä½œç”¨ [SMARCA1_ATAC-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309829">GSE309829ï¼šå¯¹äººå¤šèƒ½å¹²ç»†èƒæ¥æºçš„å¿ƒè„å¿ƒå¤–è†œ-å¿ƒè‚Œç±»å™¨å®˜è¿›è¡Œå•ç»†èƒè½¬å½•ç»„åˆ†æï¼Œæ­ç¤ºäº†äººå¿ƒå¤–è†œæ¥æºç»†èƒåˆ†åŒ–å’Œå† çŠ¶è¡€ç®¡ä¸›å‘è‚²çš„åŸç†</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302462">GSE302462 AtNUDT11 ä»‹å¯¼çš„ dpCoA-RNA-seq å®šä¹‰äº†è¡¨è§‚è½¬å½•ç»„ dpCoA åŠ å¸½ RNA [dpCoA_seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302461">GSE302461 AtNUDT11 ä»‹å¯¼çš„ dpCoA-RNA-seq å®šä¹‰äº†è¡¨è§‚è½¬å½•ç»„ dpCoA åŠ å¸½ RNA [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE208743">GSE208743 åå¼ä½œç”¨é•¿é“¾éç¼–ç  RNA è°ƒèŠ‚ä¸è‡´ç™Œ MYC ä¿¡å·ä¼ å¯¼ç›¸å…³çš„é•¿ç¨‹æŸ“è‰²è´¨ç›¸äº’ä½œç”¨ [Iso-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316691">GSE316691 Rpd3 ç»„è›‹ç™½å»ä¹™é…°åŒ–é…¶å¯¹äººç±»çœŸèŒç—…åŸä½“ç»„ç»‡èƒæµ†èŒçš„æ¸©åº¦ä»‹å¯¼çš„å½¢æ€å‘ç”Ÿå’Œæ¯’åŠ›è‡³å…³é‡è¦</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291427">GSE291427 æ ¸ä»å®šä½çš„ KANSL2 ä½œä¸ºèƒ¶è´¨æ¯ç»†èƒç˜¤ç»†èƒä¸­æ ¸ç³–ä½“ç”Ÿç‰©åˆæˆçš„è¡¨è§‚é—ä¼ è°ƒèŠ‚å› å­ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266911">GSE266911 æ°´ç¨»ï¼ˆOryza sativaï¼‰ã€è±èŒµè¡£è—»ï¼ˆChlamydomonas reinhardtiiï¼‰å’Œå°ç«‹ç¢—è—“ï¼ˆPhyscomitrella patensï¼‰çš„é«˜é€šé‡æµ‹åºæ•°æ®</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266910">GSE266910 å°ç«‹ç¢—è—“ (Physcomitrium patens) é‡ç”Ÿå‹çš„è½¬å½•ç»„æ•°æ® (mRNA-seq)ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266909">GSE266909 è±èŒµè¡£è—»é‡ç”Ÿå‹è½¬å½•ç»„æ•°æ®ï¼ˆmRNA-seqï¼‰ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266906">GSE266906 NiPã€ehd3-1ã€sdg724-1 å’Œ ehd3 sdg724 çš„è½¬å½•ç»„æ•°æ®ï¼ˆmRNA-seqï¼‰ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266905">GSE266905 ä½¿ç”¨ HA æˆ– GFP æŠ—ä½“å¯¹ Ehd3 å’Œ SDG724 è¿›è¡Œ ChIP-seq åˆ†æã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266903">GSE266903 å°ç«‹ç¢—è—“ (Physcomitrella patens) çš„ ChIP-seqã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266902">GSE266902 è±èŒµè¡£è—» H3K4me1ã€H3K4me2ã€H3K4me3ã€H3K36me1ã€H3K36me2 å’Œ H3K36me3 çš„ ChIP-seqã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE237299">GSE237299 åŸºäºDNAç”²åŸºåŒ–çš„è¡€æ¶²æ·‹å·´ç³»ç»Ÿè‚¿ç˜¤åˆ†ç±»</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317371">GSE317371 ååŒé¶å‘ eIF4A ä»‹å¯¼çš„ç¿»è¯‘èµ·å§‹å’Œæ€¥æ€§é«“ç³»ç™½è¡€ç—…ä¸­çš„ç»†èƒå‡‹äº¡</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317300">GSE317300 çº¿ç²’ä½“åŸºå› ç»„æ¯”è¾ƒå’Œ atp8 åŠŸèƒ½åˆ†æï¼Œæ­ç¤ºè‹œè“¿ç»†èƒè´¨é›„æ€§ä¸è‚²ç—‡ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317288">GSE317288 ç ”ç©¶å‘ç°ï¼Œåµå·¢åƒµç¡¬ç¨‹åº¦å¢åŠ ï¼ˆæ¨¡æ‹Ÿåµå·¢è¡°è€ï¼‰ä¼šè¯±å¯¼åµæ³¡å‘ç”Ÿçº¤ç»´ç‚ç—‡ååº”ï¼Œå¹¶æŸå®³åµæ¯ç»†èƒè´¨é‡ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317275">GSE317275 SAGA/ATACå¤åˆç‰©ç»´æŒå¼‚å¸¸æŸ“è‰²è´¨è°ƒæ§å¹¶ä¿ƒè¿›å¼¥æ¼«æ€§ä¸­çº¿èƒ¶è´¨ç˜¤çš„è‚¿ç˜¤å‘ç”Ÿ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317041">GSE317041 é•¿ç—…æ–¹æ²»ç–—æ”¾å°„æ€§è‚ ç‚å¤§é¼ æ¨¡å‹è‚ é“ç»„ç»‡è½¬å½•ç»„åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317025">GSE317025 Wnt æ¿€æ´»å’ŒåŒé‡ SMAD æŠ‘åˆ¶è¯±å¯¼å’Œç»´æŒ hiPSCs ä¸­ç±»ä¼¼åè„‘çš„ç¥ç»å¹²ç»†èƒ [scRNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317019">GSE317019 æ…¢æ€§TCRä¿¡å·é©±åŠ¨çš„FOXO1-KLHL6è½´æŠ‘åˆ¶ä¿ƒè¿›Tç»†èƒè€—ç«­</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315930">GSE315930 æ¯”è¾ƒè½¬å½•ç»„å­¦æ­ç¤ºäº†å…°ç§‘æ¤ç‰© Dactylorhiza majalis åŸçƒèŒå¯¹ç”°é—´å’Œä½“å¤–ç”Ÿé•¿æ¡ä»¶çš„ååº”ä¸»è¦åœ¨å¹…åº¦ä¸Šå­˜åœ¨å·®å¼‚ï¼Œè€Œä¸æ˜¯æ¨¡å¼ä¸Šçš„å·®å¼‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291437">GSE291437 å“ºä¹³åŠ¨ç‰©ç»†èƒä¸­ PspCas13b å’Œ RfxCas13d çš„ gRNA ä¾èµ–æ€§å’Œ gRNA éä¾èµ–æ€§è„±é¶ç»“åˆä½ç‚¹çš„è¡¨å¾ [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE261461">GSE261461 å®šä¹‰è¡€æ¶²å’Œå¤§è„‘ç»†èƒç±»å‹ä¹‹é—´ä¸€è‡´çš„è½¬å½•ç»„ç‰¹å¾ï¼Œå¹¶ä¸æ™®æ‹‰å¾·-å¨åˆ©ç»¼åˆå¾çš„ä¸¥é‡ç¨‹åº¦ç›¸å…³ã€‚</a></li></ul></div></details><hr><p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2026-01-27 21:39</em><br><em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/research/ rel=tag>Research</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/daily/ rel=tag>Daily</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/week052026/ rel=tag>Week052026</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/dailyreports/2026-01-27/ rel=prev><span class=pager__subtitle>Â«&#8201;Previous</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2026-01-27</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=../../../posts/dailyreports/2026-01-29/ rel=next><span class=pager__subtitle>Next&#8201;Â»</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2026-01-29</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Searchâ€¦ name=q aria-label=Searchâ€¦>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-24/>ç§‘ç ”æ—¥æŠ¥ 2026-02-24</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-23/>ç§‘ç ”æ—¥æŠ¥ 2026-02-23</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-22/>ç§‘ç ”æ—¥æŠ¥ 2026-02-22</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-21/>ç§‘ç ”æ—¥æŠ¥ 2026-02-21</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-20/>ç§‘ç ”æ—¥æŠ¥ 2026-02-20</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/dailyreport/>DailyReport</a></li><li class=widget__item><a class=widget__link href=../../../categories/learnr/>LearnR</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/daily/ title=Daily>Daily (117)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/research/ title=Research>Research (117)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week022026/ title=Week022026>Week022026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week032026/ title=Week032026>Week032026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week042026/ title=Week042026>Week042026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week052026/ title=Week052026>Week052026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week062026/ title=Week062026>Week062026 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week072026/ title=Week072026>Week072026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week082026/ title=Week082026>Week082026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week452025/ title=Week452025>Week452025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week462025/ title=Week462025>Week462025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week472025/ title=Week472025>Week472025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week482025/ title=Week482025>Week482025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week492025/ title=Week492025>Week492025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week502025/ title=Week502025>Week502025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week512025/ title=Week512025>Week512025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week522025/ title=Week522025>Week522025 (7)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2026 ç”Ÿä¿¡æ™®æ‹‰æ–¯.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>